Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.

Bakeer N, James J, Roy S, Wansapura J, Shanmukhappa SK, Lorenz JN, Osinska H, Backer K, Huby AC, Shrestha A, Niss O, Fleck R, Quinn CT, Taylor MD, Purevjav E, Aronow BJ, Towbin JA, Malik P.

Proc Natl Acad Sci U S A. 2016 Aug 8. pii: 201600311. [Epub ahead of print]

2.

Cardiovascular complications and risk of death in sickle-cell disease.

Gladwin MT.

Lancet. 2016 Jun 18;387(10037):2565-74. doi: 10.1016/S0140-6736(16)00647-4. Review.

PMID:
27353687
3.

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Hambleton IR, Cho G.

Cochrane Database Syst Rev. 2016 May 20;(5):CD008360. doi: 10.1002/14651858.CD008360.pub4. Review.

PMID:
27198469
4.

Chronic Pulmonary Complications of Sickle Cell Disease.

Mehari A, Klings ES.

Chest. 2016 May;149(5):1313-24. doi: 10.1016/j.chest.2015.11.016. Epub 2016 Jan 13. Review.

PMID:
26836905
5.

Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.

PMID:
26672090
6.

Increased Red Blood Cell Stiffness Increases Pulmonary Vascular Resistance and Pulmonary Arterial Pressure.

Schreier DA, Forouzan O, Hacker TA, Sheehan J, Chesler N.

J Biomech Eng. 2016 Feb;138(2):021012. doi: 10.1115/1.4032187.

PMID:
26638883
7.

A Sickle Cell Disease Patient with Severe Tricuspid Regurgitation and Early Developed Pulmonary Hypertension.

Vaidya G, Sarwar M, Sun Z, Wei T, Liu K.

Intern Med. 2015;54(19):2459-62. doi: 10.2169/internalmedicine.54.4463. Epub 2015 Oct 1.

8.

Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Arumugam PI, Mullins ES, Shanmukhappa SK, Monia BP, Loberg A, Shaw MA, Rizvi T, Wansapura J, Degen JL, Malik P.

Blood. 2015 Oct 8;126(15):1844-55. doi: 10.1182/blood-2015-01-625707. Epub 2015 Aug 18.

9.

Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study.

Mushemi-Blake S, Melikian N, Drasar E, Bhan A, Lunt A, Desai SR, Greenough A, Monaghan MJ, Thein SL, Shah AM.

PLoS One. 2015 Aug 13;10(8):e0135472. doi: 10.1371/journal.pone.0135472. eCollection 2015.

10.

Critical Reviews: How we treat sickle cell patients with leg ulcers.

Minniti CP, Kato GJ.

Am J Hematol. 2016 Jan;91(1):22-30. doi: 10.1002/ajh.24134. Epub 2015 Aug 14. Review.

PMID:
26257201
11.

Evaluation of cardiac sequelae in patients with sickle cell anemia.

Amoozgar H, Dastgheib L, Seifi V, Karimi M.

Hellenic J Cardiol. 2015 May-Jun;56(3):242-6.

12.

Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients.

Wonkam A, Makani J, Ofori-Aquah S, Nnodu OE, Treadwell M, Royal C, Ohene-Frempong K; Members of the H3Africa Consortium.

Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S50-5. doi: 10.5830/CVJA-2015-040. Review.

13.

Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.

Caughey MC, Poole C, Ataga KI, Hinderliter AL.

Br J Haematol. 2015 Aug;170(3):416-24. doi: 10.1111/bjh.13447. Epub 2015 Apr 9. Review.

PMID:
25854714
14.

Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia.

Rotz SJ, O'Riordan MA, Kim C, de Lima M, Gladwin MT, Little JA.

Bone Marrow Transplant. 2015 Jul;50(7):918-23. doi: 10.1038/bmt.2015.11. Epub 2015 Mar 16.

PMID:
25774596
15.

Pulmonary hypertension in sickle cell disease: diagnosis and management.

Ataga KI, Klings ES.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):425-31. doi: 10.1182/asheducation-2014.1.425. Epub 2014 Nov 18. Review.

PMID:
25696889
16.

Non-invasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: an echocardiographic study.

Enakpene EO, Adebiyi AA, Ogah OS, Olaniyi JA, Aje A, Adeoye MA, Falase AO.

Acta Cardiol. 2014 Oct;69(5):505-11.

17.

N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease.

Schimmel M, van Beers EJ, van Tuijn CF, Nur E, Rijneveld AW, Mac Gillavry MR, Brandjes DP, Schnog JJ, Biemond BJ; CURAMA study group.

Am J Hematol. 2015 Apr;90(4):E75-6. doi: 10.1002/ajh.23944. Epub 2015 Feb 2. No abstract available.

18.

[Chronic complications of sickle cell disease].

Bartolucci P, Lionnet F.

Rev Prat. 2014 Oct;64(8):1120-6. French.

PMID:
25510140
19.

MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.

Li C, Gonsalves CS, Eiymo Mwa Mpollo MS, Malik P, Tahara SM, Kalra VK.

Mol Cell Biol. 2015 Feb;35(3):514-28. doi: 10.1128/MCB.01199-14. Epub 2014 Nov 17.

20.

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk